Search results for "Highlights"

Results 1 - 10 of about 426 for "Highlights".
Sort by: Relevance | Newest | Oldest

Women more likely to have pain with diabetic peripheral neuropathy

Cardiometabolic factors traditionally associated with microvascular disease were not associated with risk for painful diabetic peripheral neuropathy in patients with type 1 diabetes, a European study found.
10 Nov 2023


ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomes

The effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on gout in patients with type 2 diabetes or heart failure (HF) may allow reduced polypharmacy when treatment for gout is also needed, an ACP Journal Club commentary said.
10 Nov 2023

High-normal albumin-to-creatinine ratio associated with CV events in type 2 diabetes

Patients with an elevated urinary albumin-to-creatinine ratio, even below 30 mg/g, were at increased risk for major adverse cardiovascular (CV) events, a post hoc analysis of the ACCORD trial found.
10 Nov 2023

Diabetes patients lost more weight with time-restricted eating than calorie counting

Over the course of six months, eating only between noon and 8 p.m. had a greater impact on weight loss and a similar effect on HbA1c levels compared with reducing energy intake by 25%, according to a small randomized trial of patients with type 2 diabetes and obesity.
10 Nov 2023

Report and study highlight risk of heart failure in patients with diabetes

The American Diabetes Association made recommendations on diagnosing and treating heart failure in patients with diabetes, and a study found increased risk of progression to clinical heart failure in those with an HbA1c level of 7% or above.
10 Jun 2022

Higher aspirin dose no more effective for CV prevention in high-risk patients with diabetes

A subgroup analysis of a randomized trial found that patients with diabetes and atherosclerotic cardiovascular (CV) disease had similar outcomes whether they took 81 mg or 325 mg of aspirin daily.
13 Oct 2023

CT as effective as angiography as first test for patients with diabetes, chest pain

Patients with diabetes and stable chest pain had no difference in major adverse cardiac events if they underwent cardiac CT first when they were referred for invasive coronary angiography, and they had fewer procedure-related complications with a CT-first strategy.
13 Oct 2023

Young adults' lack of regular diabetes care may be linked to beliefs about medication

Follow-up research from the TODAY study found that a quarter of participants, ages 19 to 31 years, lacked a usual place for diabetes care and almost half had an urgent care visit in the past year. Belief in the necessity of medications was associated with regular access to care.
11 Aug 2023

SGLT-2 inhibitors, GLP-1 receptor agonists beat DPP-4s, sulfonylureas in pragmatic trial

Veterans with diabetes who started sodium-glucose cotransporter-2 (SGLT-2) inhibitors or glucagon-like peptide-1 (GLP-1) receptor agonists had fewer major adverse cardiovascular events than those initiating dipeptidyl peptidase-4 (DPP-4) inhibitors or sulfonylureas.
11 Aug 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next